Skip to content

Comparison of electroacupuncture and manual acupuncture in the treatment of plantar fasciitis: a randomized controlled trial

Comparison of electroacupuncture and manual acupuncture in the treatment of plantar fasciitis: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016531
Enrollment
Unknown
Registered
2018-06-07
Start date
2018-10-01
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

plantar fasciitis

Interventions

Group 2:manual acupuncture

Sponsors

Guang'an Men Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Pain localized to the plantar medial aspect of the heel along the insertion of the plantar fascia; (2) Most noticeable plantar medial heel pain with initial steps after a period of inactivity (e.g., initial steps in the morning) but also worse following prolonged weight bearing; (3) palpation/provocation over the medial calcaneal tuberosity or along the plantar fascia; (4) Active and passive talocrural dorsiflexion range of motion; (5) Positive windlass test as well as negative result of tarsal tunnel tests; (6) A minimum score of 40 in worst pain intensity at first steps in the morning according to the 100-point visual analog scale (VAS) (7) aged from 18 to 75 years; (8) signed the informed consent prior to inclusion.

Exclusion criteria

Exclusion criteria: (1) A history of ankle and foot fracture, surgery or tumor, or have a foot deformity; (2) A history of plantar fascia rupture, nerve entrapment syndrome, or achilles tendon lesions; (3) Neurological or systemic diseases including rheumatoid arthritis, diabetes, cardiovascular disorder, severe hepatic/renal insufficiency, or coagulation disorder; (4) Existing systemic or local infection, or chapped heel skin; (5) Used local corticosteroid injections in the last 6 months; (6) Needle-phobic patients or had received EA or MA in the past 4 weeks.

Design outcomes

Primary

MeasureTime frame
the proportion of patients with at least 50% reduction from baseline in the worst pain intensity measured by visual analog scale (0 to 100, higher scores signify worse pain) at first steps in the morning after 4-week treatment.;

Secondary

MeasureTime frame
Change in worst pain intensity measured by VAS at first steps in the morning;Change in mean pain intensity measured by VAS at first steps in the morning;Change in worst pain intensity measured by VAS during the day (before bed time);Change in the pressure pain threshold(PPT) at the most painful spot;Change in ankle-dorsiflexion range of motion (DFROM);Change in FAAM (Foot and Ankle Ability Measure) total score and subscale scores;Patients' global improvement assessment;Patients' expectations for acupuncture;Use of other treatment during study;Change in mean pain intensity measured by VAS during the day (before bed time);

Countries

China

Contacts

Public ContactWang Weiming

Guang'an Men Hospital, China Academy of Chinese Medical Sciences

wangweiming1a1@163.com+86 13426424993

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026